Current state and future prospects of direct-to-consumer (DTC) pharmacogenetics

Current state and future prospects of direct-to-consumer (DTC) pharmacogenetics

Direct-to-consumer (DTC) DNA testing has grown from contentious beginnings into a global industry, by providing a wide range of personal genomic information directly to its clients. These companies, typified by the well-established 23andMe, generally carry out a gene-chip analysis of single nucleoti...

Full description

Bibliographic Details
Main Authors: Eng Wee eChua, Martin A Kennedy
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-08-01
Series:Frontiers in Pharmacology
Subjects:
Genetic Testing
Pharmacogenetics
pharmacogenomics
personalized medicine
direct-to-consumer (DTC)
personal genome
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00152/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00152/full

Similar Items